Prenatal Testing Guide

NIPT vs Diagnostic Prenatal Testing in Nepal Screening or Diagnosis? Understanding the Difference

NIPT is a safe blood-based screening test from 10 weeks; CVS and amniocentesis are invasive diagnostic tests with a small miscarriage risk. This guide explains when each is appropriate in Nepal.

Medically Reviewed Content

Reviewed by: Thamel Clinic Clinical Team (MBBS, MD)

Last medical review: November 8, 2026

Next scheduled review: May 8, 2027

This content follows evidence-based medical guidelines and is regularly updated to reflect current medical practices.

Important Safety Information

  • NIPT is a screening test — never make decisions about a pregnancy based on a screening result alone; always confirm with a diagnostic test.
  • CVS and amniocentesis carry a small miscarriage risk — ensure the procedure is performed by an experienced specialist under ultrasound guidance.
  • A high-risk result can be distressing — seek genetic counselling before making any decisions about the pregnancy.
  • Results timing matters: do not delay diagnostic confirmation if a screening result is high-risk, as earlier diagnosis preserves more options.
  • If you have a family history of chromosomal conditions or a previous affected pregnancy, tell your clinician early — it changes which tests are appropriate.

Prenatal Testing in Nepal

  • Availability in Kathmandu — NIPT is now offered through several private laboratories and clinics in Kathmandu, typically requiring blood drawn at the clinic and sent to a reference lab, with results in about one to two weeks.
  • Cost considerations — NIPT in Nepal typically costs several thousand NPR, considerably more than basic ultrasound and blood screening, so it is often chosen by higher-risk or higher-income families.
  • Invasive testing access — CVS and amniocentesis require trained specialists and ultrasound guidance; these are available mainly at larger hospitals in Kathmandu and are less commonly performed than NIPT.
  • Sonography norms — The 11–13 week and 20-week anomaly scans are widely available and remain the foundation of prenatal screening; NIPT complements rather than replaces ultrasound.
  • Counselling gaps — Genetic counselling is still limited in Nepal, so couples may receive test results without full explanation — seeking a clinician who discusses what a screen does and does not mean is important.
  • Referral pathways — Women receiving a high-risk result usually need referral to a centre offering diagnostic testing and counselling; planning this pathway before testing avoids delays.

NIPT vs Diagnostic Prenatal Testing — Overview

Prenatal testing for chromosomal conditions falls into two fundamentally different categories. Screening tests — including NIPT (non-invasive prenatal testing), the quadruple screen and the combined first-trimester test — estimate the probability that a pregnancy is affected. Diagnostic tests — chorionic villus sampling (CVS) and amniocentesis — examine fetal cells directly and give a definitive answer. Confusing the two is the most common source of misunderstanding in prenatal care.

NIPT analyses cell-free fetal DNA circulating in the mother’s blood from around 10 weeks of pregnancy. It is highly accurate for trisomy 21, 18 and 13 — detection rates above 99% for Down syndrome in many studies — but it remains a screening test. A positive NIPT result must be confirmed by a diagnostic test before any conclusion is drawn, because false positives do occur.

CVS samples placental tissue (which shares the fetus’s chromosomes) from around 11–13 weeks; amniocentesis samples amniotic fluid from around 15–20 weeks. Both give a karyotype or chromosomal microarray result that is essentially definitive. The trade-off is a small procedure-related miscarriage risk, quoted in most modern series at roughly 0.1–0.5%, plus rare complications such as infection or leaking fluid.

The standard pathway in Nepal is screening first, diagnostic confirmation only when indicated. NIPT is appropriate for most pregnancies, while diagnostic testing is reserved for high-risk situations: advanced maternal age, abnormal ultrasound findings, a high-risk screening result, a known chromosomal rearrangement in a parent, or a previous affected pregnancy. Genetic counselling helps couples understand which path applies to them.

What NIPT Actually Measures

NIPT isolates cell-free DNA — small fragments of DNA released into the maternal bloodstream from the placenta — and measures the proportion of fetal (placental) DNA among the total. Because the placenta and fetus share essentially the same chromosomes, abnormal chromosome proportions indicate a likely fetal chromosomal condition. It screens for trisomies 21, 18 and 13 and can report fetal sex and some microdeletion conditions, though accuracy for microdeletions is lower.

The test can be performed from about 10 weeks of pregnancy, requires only a maternal blood draw, and carries no miscarriage risk — its great advantage over invasive testing. However, a small percentage of samples return "no result" because the fetal fraction is too low, often in early pregnancy, in higher-weight mothers, or with certain placental conditions.

Crucially, NIPT is a screen, not a diagnosis. Positive predictive value depends on the mother’s background risk: in a low-risk 25-year-old, even a high-sensitivity screen produces more false positives than true ones. This is why professional guidelines consistently require diagnostic confirmation before acting on a positive NIPT.

  • Screens for trisomy 21 (Down), trisomy 18 (Edwards) and trisomy 13 (Patau)
  • Also reports fetal sex and selected microdeletion conditions
  • Available from around 10 weeks; only a maternal blood sample needed
  • No miscarriage risk, unlike CVS and amniocentesis
  • A small percentage of tests return no result — usually repeatable later
  • Not a diagnosis: positive results require diagnostic confirmation

Cell-free DNA

Placental DNA fragments in maternal blood reveal the fetus’s chromosomal pattern without touching the pregnancy.

High sensitivity

Detection rates for Down syndrome exceed 99% in most studies, with false-negative rates under 1%.

Screening limits

A positive NIPT indicates elevated probability, not certainty — false positives mean diagnostic confirmation is mandatory.

Safe timing

Because it is blood-only, NIPT can be done early — from about 10 weeks — with zero procedure-related miscarriage risk.

CVS and Amniocentesis — the Diagnostic Tests

CVS obtains a small sample of chorionic villi — placental tissue that shares the fetus’s genetic makeup — typically between 11 and 14 weeks via the cervix or abdomen under ultrasound guidance. Amniocentesis obtains amniotic fluid containing fetal cells, usually from around 15–20 weeks. Both samples are cultured and analysed by karyotyping or chromosomal microarray, giving a definitive chromosomal diagnosis.

Because they sample fetal material directly, diagnostic tests have essentially 100% accuracy for the conditions tested — there is no "maybe" about the result. Microarray analysis can also detect smaller deletions and duplications that NIPT and standard karyotyping miss.

The cost of certainty is a small but real risk. Modern series quote procedure-related miscarriage rates around 0.1–0.5% for both procedures, plus rare risks of infection, bleeding or fluid leakage. These risks, while small, are why invasive testing is reserved for pregnancies where the answer genuinely changes management — or where a definitive answer is needed for decisions.

  • CVS: placental biopsy at 11–14 weeks; results in 1–2 weeks
  • Amniocentesis: amniotic fluid at 15–20+ weeks; slightly safer timing window
  • Chromosomal microarray detects more abnormalities than karyotype alone
  • Definitive results — no false-positive ambiguity
  • Small miscarriage risk of roughly 0.1–0.5% with experienced operators
  • Requires ultrasound guidance and trained specialists

CVS

Earlier testing at 11–14 weeks from placental tissue; slightly higher miscarriage risk than amniocentesis in some series.

Amniocentesis

From about 15 weeks, sampling amniotic fluid; the standard diagnostic test for most indications.

Microarray analysis

Detects submicroscopic chromosomal changes that karyotyping and NIPT may miss.

Definitive answer

A diagnostic result ends uncertainty — critical when decisions about pregnancy management depend on it.

Screening First or Going Straight to Diagnosis

For most pregnancies, screening is the correct first step. A low-risk woman with a normal ultrasound and reassuring screening result does not need invasive testing — the risks of CVS or amniocentesis outweigh the benefit of information she does not need. NIPT fits this pathway perfectly: safe, early, and highly accurate.

Diagnostic testing is indicated — or at least strongly considered — in several situations. Advanced maternal age (35 and over) raises baseline risk. An abnormal or inconclusive screening result, an ultrasound anomaly, a previous pregnancy with a chromosomal condition, a known parental translocation, or a family history all shift the balance toward definitive testing, often skipping or following quickly after screening.

The practical sequence most clinicians recommend: dating ultrasound, first-trimester screening (nuchal translucency and bloods) or NIPT, the 20-week anomaly scan, and diagnostic testing only if something abnormal appears at any stage. This sequential approach minimises risk while never missing an indication for diagnosis.

  • Low-risk pregnancy: screening (NIPT or combined test) is sufficient
  • Age 35+: discuss whether NIPT alone or diagnostic testing is preferable
  • Abnormal screening or ultrasound: diagnostic confirmation needed
  • Previous affected pregnancy or parental translocation: diagnostic testing indicated
  • Positive NIPT: always confirm with CVS or amniocentesis before decisions
  • Genetic counselling helps weigh screening vs diagnostic for your situation

Low-risk pathway

Most pregnancies need only screening plus ultrasound — invasive testing adds risk without benefit.

High-risk indications

Age, abnormal scans, family history or positive screens are the accepted reasons for diagnostic testing.

Positive NIPT

A high-risk NIPT result is an indication for diagnostic confirmation, not for decisions on its own.

Counselling-led choice

When both paths are reasonable, genetic counselling helps the couple choose based on their values and risk.

Cost, Timing and Practical Considerations

NIPT is considerably cheaper and more accessible than diagnostic testing. In Nepal it is offered privately at a fraction of the cost of travelling abroad for the same service, though it is still priced above routine antenatal blood tests. Samples are typically collected at the clinic and sent to a reference laboratory, with results in roughly one to two weeks.

CVS and amniocentesis are available mainly at larger Kathmandu hospitals and require specialist referral, ultrasound guidance and sometimes a waiting period for theatre slots. They are more expensive than NIPT and carry the small miscarriage risk discussed above. For families where a definitive answer is essential — for example to inform termination decisions — this cost and risk is usually accepted.

Timing matters for both. NIPT needs about 10 weeks; CVS fits in the first trimester; amniocentesis is usually performed in the second trimester. Decisions about continuing or ending a pregnancy are easier earlier, which is one reason first-trimester screening is preferred where possible. Couples should discuss timing at their first antenatal visit.

  • NIPT: from ~10 weeks, results in 1–2 weeks, no procedure risk
  • CVS: 11–14 weeks, needs specialist and ultrasound guidance
  • Amniocentesis: ~15–20 weeks, the standard second-trimester diagnostic
  • NIPT costs less than diagnostic testing; both are private-pay in Nepal
  • Earlier diagnosis allows more options — first-trimester screening is preferred

NIPT logistics

A simple blood draw at the clinic; results typically within one to two weeks.

Diagnostic logistics

Requires referral to a specialist centre with ultrasound and procedural expertise.

Cost reality

NIPT is a few thousand NPR in Nepal; diagnostic procedures cost more and need hospital facilities.

Decision timing

Earlier results preserve more options — the reason first-trimester screening is standard practice.

Common Misconceptions

The most damaging misconception is that a "high-risk" NIPT result means the baby has the condition. It does not — it means the probability is elevated, and most high-risk results in low-risk pregnancies turn out to be false positives after diagnostic testing. Conversely, a "low-risk" NIPT does not guarantee an unaffected pregnancy, though the residual risk is very small.

Another misconception is that diagnostic testing is dangerous and should always be avoided. The miscarriage risk is real but small, and in high-risk pregnancies the value of a definitive answer typically outweighs it — particularly when the result will guide management. A third misconception is that NIPT can detect everything; it screens mainly for the common trisomies and cannot exclude all genetic conditions.

Finally, some couples believe screening is only for older mothers. Chromosomal conditions occur at every age, and guidelines recommend offering screening to all pregnant women regardless of age — the difference is in which tests are most appropriate, not whether to screen at all.

  • High-risk NIPT ≠ diagnosis — confirmatory testing is always required
  • Low-risk NIPT ≠ guarantee — residual risk remains, though very small
  • Diagnostic testing risk is small and justified when results change management
  • NIPT does not detect all genetic conditions — it targets common trisomies
  • Screening is offered to all pregnant women, not just older mothers

Screen vs diagnosis

Screening estimates probability; diagnosis gives certainty — confusing them leads to wrong decisions.

False positives

Even accurate screens produce false positives, especially in low-risk pregnancies — confirmation is essential.

Invasive test fear

The 0.1–0.5% risk is small; for high-risk pregnancies the definitive answer usually justifies it.

Universal screening

All pregnant women should be offered screening — age changes the choice of test, not whether to test.

Prenatal Testing Services & Costs

ServiceWhat It IncludesCost (NPR)
Prenatal consultationCounselling on screening vs diagnostic options and timingRs. 450
Dating / viability ultrasoundEarly pregnancy scan confirming dates and viabilityRs. 1,500–2,500
NIPTCell-free DNA screening for trisomies 21, 18, 13 and sexRs. 15,000–25,000
First-trimester combined screeningNuchal translucency ultrasound plus blood markersRs. 3,000–5,000
20-week anomaly scanDetailed structural ultrasound of the fetusRs. 3,000–5,000
CVS / amniocentesisDiagnostic sampling — referral to specialist centre requiredPer procedure — enquire
Genetic counselling sessionDiscussion of results and options with a clinicianRs. 1,000–2,000

Indicative NPR pricing; confirm current rates when booking. Diagnostic procedures require specialist referral.

Why Patients Choose Thamel Clinic for Prenatal Counselling

  • Clear explanations — we explain what screening can and cannot tell you, in plain language, before you decide.
  • Correct sequencing — screening first, diagnostic only when indicated — following international guidelines.
  • Honest about limits — no test is perfect; we explain false positives, no-results and residual risk honestly.
  • Referrals coordinated — when diagnostic testing is needed, we connect you to the appropriate specialist centre.
  • Transparent pricing — clear NPR costs for every test so families can plan without surprises.
  • Confidential service — private consultations and discreet handling of all results.
  • Experienced team — clinicians experienced in prenatal counselling and sexual/reproductive health.

Frequently Asked Questions

What is the difference between NIPT and amniocentesis?

NIPT is a screening blood test that estimates the probability of chromosomal conditions — it is highly accurate but not definitive. Amniocentesis is a diagnostic test that samples amniotic fluid and gives a definitive answer, but carries a small miscarriage risk.

Is NIPT safer than amniocentesis?

Yes. NIPT requires only a maternal blood draw and has no miscarriage risk. Amniocentesis and CVS carry a small procedure-related miscarriage risk of roughly 0.1–0.5%.

If my NIPT comes back high-risk, does that mean my baby has Down syndrome?

No. A high-risk NIPT means the probability is elevated — not that the condition is confirmed. Most high-risk NIPT results in low-risk pregnancies are false positives after diagnostic confirmation.

When should I have NIPT?

NIPT can be performed from about 10 weeks of pregnancy. Earlier testing gives more time for follow-up if needed, so most clinicians recommend it in the first trimester.

Do I need CVS or amniocentesis if my NIPT is normal?

Usually not. A low-risk NIPT in a low-risk pregnancy is reassuring. Diagnostic testing is reserved for high-risk situations such as abnormal ultrasound, advanced maternal age or a positive screen.

How accurate is NIPT?

For trisomy 21, detection rates exceed 99% with false-positive rates around 0.1%. Accuracy is lower for trisomies 18 and 13 and for microdeletion conditions.

How much does NIPT cost in Nepal?

NIPT in Kathmandu typically costs roughly Rs. 15,000–25,000 depending on the laboratory and panel. Diagnostic procedures are additional and require specialist facilities.

Can NIPT tell the baby’s sex?

Yes, most NIPT panels report fetal sex from around 10 weeks. Accuracy is very high but not absolute, and sex determination may be restricted for non-medical reasons in some settings.

What if my NIPT returns no result?

A small percentage of tests return no result because fetal DNA fraction is too low — often early in pregnancy or in higher-weight mothers. A repeat test a week or two later usually succeeds.

Should every pregnant woman be screened?

Yes. Screening is offered to all pregnant women regardless of age. Age and risk factors influence which tests are most appropriate, not whether to screen.

What happens after a positive screening result?

You will be offered genetic counselling and diagnostic testing — CVS or amniocentesis — to confirm or exclude the condition before any decisions are made.

Still have questions? Contact us or book an appointment for personalized guidance.

Related Services & Guides

Related Health Guides

Medical Review & Sources

Medically reviewed by: Thamel Clinic Clinical Team (MBBS, MD)

Role: Prenatal counselling and sexual/reproductive health reviewers, Thamel Clinic, Kathmandu

Last reviewed: 2026-11-08

Reviewed against current WHO, ACMG and FIGO guidance on prenatal screening. This is general medical information; a registered clinician must assess each patient before decisions.

View clinic team and credentials

Medical information is general guidance only and does not replace an individual consultation. Treatment decisions are made after clinical assessment, including allergy and pregnancy review.

Medical Disclaimer

Important information about using this medical website

Educational Purpose Only

The information provided on this website, including all text, graphics, images, and other material, is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

No Doctor-Patient Relationship

Use of this website does not create a doctor-patient relationship. The information provided is not tailored to your specific medical condition or health needs. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Emergency Situations

If you think you may have a medical emergency, call your doctor or emergency services immediately. In Nepal, call 102 for emergency services or go to the nearest hospital emergency room.

Emergency Contact Information:

National Emergency:

102 (Ambulance)

Our Clinic:

+977-9700682800 (WhatsApp available 24/7)

Bir Hospital Emergency:

+977-1-4412400

TU Teaching Hospital:

+977-1-4434320

Timeliness of Information

Medical information changes rapidly. While we strive to provide current and accurate information, we make no guarantees about the completeness, accuracy, reliability, suitability, or availability with respect to the website or the information contained on the website.

Professional Medical Advice Required

Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you have any specific questions about any medical matter, you should consult your doctor or other professional healthcare provider.

Treatment and Diagnosis

Do not use the information on this website to diagnose or treat any health problem or disease. The descriptions of treatments and medications provided are for general informational purposes only and do not constitute medical advice.

Limitation of Liability

In no event shall we be liable for any loss or damage arising from the use of this website or reliance on the information provided herein. This includes, but is not limited to, direct, indirect, incidental, punitive, and consequential damages.

Nepal-Specific Considerations

This website is operated in Nepal and is intended for users in Nepal. The medical information provided may not be applicable to healthcare systems outside Nepal. Always consult with local healthcare providers familiar with Nepal's healthcare system and regulations.

Last Updated: November 20, 2026 |Clinic: Thamel Clinic |Licensed: Registered

WhatsAppBook Now